Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Symptomatic Polycystic Liver Disease

NCT05281328 is registered in ClinicalTrials.gov with Camurus AB as lead sponsor.

NCT NCT05281328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05281328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Symptomatic Polycystic Liver Disease
Lead sponsor
Camurus AB
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
June 28, 2022
Completion date
August 31, 2027
Enrollment
71 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic liver disease